Literature DB >> 12060798

CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons.

Eun Sang Choe1, John Q Wang.   

Abstract

Amphetamine activates extracellular signal-regulated kinase 1 and 2 (ERK1/2) resulting in cAMP response element-binding protein (CREB) and Elk-1 phosphorylation in striatal neurons. In the present study we investigated whether calcium and calmodulin-dependent protein kinase II (CaMKII) regulates amphetamine-induced ERK1/2 pathways in striatal neurons using Western blot and immunohistochemical analysis. Acute administration of amphetamine (5 mg/kg, i.p.) increased phosphorylated (p)CaMKII immunoreactivity. Inhibition of CaMKII by intrastriatal infusion of KN62 (2, 10, or 25 nmol) attenuated amphetamine-induced increases in pERK1/2, pCREB, and pElk-1 immunoreactivity in the ipsilateral dorsal striatum in a dose-dependent manner. These data suggest that CaMKII controls amphetamine-activated ERK1/2 pathways in striatal neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060798     DOI: 10.1097/00001756-200206120-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

2.  Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.

Authors:  Padmanabhan Mannangatti; Obulakshmi Arapulisamy; Toni S Shippenberg; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 3.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

5.  Inhibition of basal and amphetamine-stimulated extracellular signal-regulated kinase (ERK) phosphorylation in the rat forebrain by muscarinic acetylcholine M4 receptors.

Authors:  Nan He; Li-Min Mao; Adrian W Sturich; Dao-Zhong Jin; John Q Wang
Journal:  Brain Res       Date:  2018-03-22       Impact factor: 3.252

6.  A causative link between inner ear defects and long-term striatal dysfunction.

Authors:  Michelle W Antoine; Christian A Hübner; Joseph C Arezzo; Jean M Hébert
Journal:  Science       Date:  2013-09-06       Impact factor: 47.728

7.  Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.

Authors:  Mufida B El-Ghundi; Theresa Fan; Joanna M Karasinska; John Yeung; Millee Zhou; Brian F O'Dowd; Susan R George
Journal:  Psychopharmacology (Berl)       Date:  2009-10-15       Impact factor: 4.530

8.  Regulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors.

Authors:  Bing Xue; Li-Min Mao; Dao-Zhong Jin; John Q Wang
Journal:  J Neurosci Res       Date:  2015-07-08       Impact factor: 4.164

9.  Amphetamine increases phosphorylation of MAPK/ERK at synaptic sites in the rat striatum and medial prefrontal cortex.

Authors:  Li-Min Mao; James M Reusch; Eugene E Fibuch; Zhenguo Liu; John Q Wang
Journal:  Brain Res       Date:  2012-11-29       Impact factor: 3.252

10.  N-methyl-D-aspartate receptors mediate diphosphorylation of extracellular signal-regulated kinases through Src family tyrosine kinases and Ca2+/calmodulin-dependent protein kinase II in rat hippocampus after cerebral ischemia.

Authors:  Hui-Wen Wu; Hong-Fu Li; Jun Guo
Journal:  Neurosci Bull       Date:  2007-03       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.